Welcome to our dedicated page for Pyxus Internatio SEC filings (Ticker: PYYX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Locating crop yield data buried in Pyxus International’s 250-page reports can feel like sorting leaves at harvest. Exchange-rate swings, vaping regulations and hemp market volatility all collide in PYYX disclosures, making them uniquely intricate. Stock Titan’s AI-powered summaries turn that complexity into clarity, so you can answer questions like “Pyxus International SEC filings explained simply” without combing through footnotes.
Need the latest numbers? Our platform captures every Pyxus International quarterly earnings report 10-Q filing the moment it hits EDGAR. Curious whether insiders are buying before the next curing season? Receive instant alerts on Pyxus International Form 4 insider transactions real-time. Key filing types and what you’ll uncover:
- 10-K annual report – segment revenue from tobacco, e-liquid and CBD operations, all in one place. See it in our Pyxus International annual report 10-K simplified view.
- 10-Q quarterly update – quarter-over-quarter trends with AI ratios and “Pyxus International earnings report filing analysis”.
- 8-K – crop shortfalls or supply-chain disruptions? Get Pyxus International 8-K material events explained within minutes.
- Form 4 – drill into Pyxus International executive stock transactions Form 4 and broader “Pyxus International insider trading Form 4 transactions”.
- DEF 14A proxy – review “Pyxus International proxy statement executive compensation” with AI-highlighted ESG pay links.
Whether you’re comparing segment margins, monitoring litigation reserves, or tracking sustainability goals, Stock Titan delivers comprehensive, real-time coverage and plain-language explanations. Stop wrestling with dense documents—start understanding Pyxus International SEC documents with AI in seconds.
Pyxus International, Inc. (PYYX) reported a new equity award to one of its directors. On November 20, 2025, the director received 10,980 restricted stock units (RSUs), each representing a contingent right to receive one share of Pyxus common stock.
The RSUs are earned for vesting based on continued board service through the earlier of August 14, 2026 or the commencement of the 2026 annual shareholders meeting, with a prorated amount earned if service ends earlier. Vesting is further contingent on the earliest of March 31, 2031, a defined Change in Control transaction, or Pyxus common stock being listed for trading on a registered or approved foreign securities exchange. Following this grant, the director beneficially owns 10,980 derivative securities directly.
Pyxus International, Inc. (PYYX) reported a director equity award of 10,980 restricted stock units (RSUs). Each RSU represents a right to receive one share of Pyxus common stock.
The RSUs were granted on November 20, 2025 and are earned based on continued board service through the earlier of August 14, 2026 or the company’s 2026 annual shareholders meeting, with prorated earning if service ends sooner. Vesting is further contingent on the earliest of March 31, 2031, a qualifying change in control transaction, or Pyxus common stock becoming listed for trading on a registered U.S. or approved foreign securities exchange.
Pyxus International, Inc. reported an equity grant to one of its directors in the form of 10,980 restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Pyxus common stock at a future date.
The RSUs were awarded on November 20, 2025 and are to be earned for vesting based on continued board service through the earlier of August 14, 2026 or the start of the 2026 annual shareholders meeting, with prorated vesting if service ends earlier. Vesting is further contingent on the earliest of March 31, 2031, a defined change in control transaction, or the company’s common stock becoming listed on a registered or approved securities exchange.
Pyxus International, Inc. (PYYX) disclosed that one of its directors received 10,980 restricted stock units (RSUs) on November 20, 2025. Each RSU represents a contingent right to receive one share of Pyxus common stock at no exercise price.
The RSUs are earned for vesting based on continued board service through the earlier of August 14, 2026 or the start of the company’s 2026 annual shareholders meeting, with a prorated amount earned if service ends earlier. Actual vesting is further contingent on the earliest of March 31, 2031, a qualifying change in control transaction under the company’s 2020 Incentive Plan, or Pyxus common stock becoming listed for trading on a registered or approved securities exchange.
Pyxus International, Inc. (PYYX) reported an equity compensation grant to one of its directors. On November 20, 2025, the director received 10,980 restricted stock units (RSUs), each representing a contingent right to receive one share of Pyxus common stock. The RSUs are earned for vesting based on continued board service through the earlier of August 14, 2026 or the start of the 2026 annual shareholders meeting, with prorated earning if service ends earlier.
Actual vesting is further contingent on the earliest of three events: March 31, 2031; a qualifying Change in Control under the company’s 2020 Incentive Plan; or Pyxus common stock being listed for trading on a U.S. or approved foreign securities exchange.
Pyxus International, Inc. furnished an 8-K announcing it issued a press release with operating and financial results for the three and six months ended September 30, 2025. The press release is included as Exhibit 99.1.
The company notes the information is furnished, not filed under Section 18 of the Exchange Act. The report lists no securities registered under Section 12(b). The date of the report and press release is November 12, 2025.
Pyxus International filed its 10‑Q reporting Q2 FY2026 results. Sales and other operating revenues were $570.2 million, up 0.7% year over year, as higher volumes and processing revenues offset lower average sales prices. Gross margin improved to 15.4% from 13.3%, and operating income rose to $46.7 million. After $37.9 million of interest expense and $10.3 million of income tax expense, the company reported a net loss of $0.9 million, or $(0.03) per share.
For the first six months, sales were $1,079.0 million, down 10.2%, with a net loss of $16.7 million. Working capital peaked seasonally: inventories increased to $1,135.2 million, and notes payable rose to $908.0 million. Net cash used in operating activities was $580.9 million, reflecting procurement in Africa and South America and timing of shipments. Long‑term debt was $455.3 million and the company remained in compliance with covenants.
The ABL Credit Facility was amended on May 12, 2025 to increase commitments to $150 million and extend maturity to 2030, and two receivables securitization programs remained active. As of October 31, 2025, common shares outstanding were 24,607,791.
FAQ
What is the current stock price of Pyxus Internatio (PYYX)?
What is the market cap of Pyxus Internatio (PYYX)?
